NL-OMON32223尚未招募2 期
Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a Phase-II and observation study (EORTC 22042-26042) - EORTC Weber meningioma study
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- EORTC
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •summary of protocol page 22:
- •Adult patients in a fair condition after resection of an intracranial atypical or malignant meningioma.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Post-Operative Radiotherapy for Selected High Risk Rectal AdenocarcinomaColorectal cancerColorectalCancerISRCTN91411631orthern and Yorkshire Clinical Trials and Research Unit (UK)
招募中
1 期
Dose-intensified neoadjuvant radiochemotherapy for operable locally advanced NSCLC Stage III A & Bnonsmall-cell lung cancer (NSCLC)C34Malignant neoplasm of bronchus and lungDRKS00010244niversitätsklinikum Essen35
进行中（未招募）
1 期
Postoperative radiochemotherapy (aRCH) with Cisplatin (C) versus aRCH with C and Pembrolizumab (P) in locally advanced head and neck squamous cell carcinoma (HNSCC)Advanced primary resectable stage III, IVA/B head and neck squamous cell carcinoma (HNSCC)MedDRA version: 21.0Level: PTClassification code 10060121Term: Squamous cell carcinoma of head and neckSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-002546-74-DEniversity Leipzig240
进行中（未招募）
1 期
Post-operative external radiotherapy combined with concomitant and adjuvant hormonal treatment versus post-operative external radiotherapy alone in pathological stage pT3a-b R0-1 N0M0 / pT2R1 N0M0, Gleason score 5-10 prostatic carcinoma. A Phase III studyEUCTR2006-002772-17-FREuropean Organisation for Research and Treatment of Cancer86
招募中
3 期
Postoperative radiotherapy (PORT) for pathological N2 non-small cell lung cancer with adjuvant chemotherapy: a randomized phase III trial (JCOG1916, J-PORT)pathological N2 non-small cell lung cancerJPRN-UMIN000042905Japan Clinical Oncology Group (JCOG)330